CQS Cayman’s Boston Scientific BSX Stock Holding History

CQS Cayman’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-14,000	Closed	-$333K	–	119
2016 Q3	$333K	Buy	+14,000	New	+$334K	0.03%	128
2015 Q3	–	Sell	-75,000	Closed	-$1.33M	–	162
2015 Q2	$1.33M	Sell	75,000 -394,000	-84%	-$7.04M	0.08%	126
2015 Q1	$8.32M	Buy	+469,000	New	+$7.41M	0.39%	53

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CQS Cayman's BSX Position: Q4 2016 in Review

CQS Cayman sold out of Boston Scientific (BSX) in Q4 2016, closing a stake of 14,000 shares — an estimated $333K sold.

CQS Cayman first reported a position in BSX in Q1 2015 and held it in 3 quarters. The position peaked at $8.32M in Q1 2015. 556 funds tracked by Wall St. Rank hold BSX as of Q4 2016.

CQS Cayman reported no remaining Boston Scientific position as of Q4 2016 after selling out during the quarter.
CQS Cayman sold 14,000 Boston Scientific shares in Q4 2016, an estimated $333K.
CQS Cayman first reported a position in Boston Scientific in Q1 2015 and held it in 3 quarters.
CQS Cayman's Boston Scientific position peaked at $8.32M in Q1 2015.
556 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2016.

Based on CQS Cayman's 13F filing for Q4 2016, filed 14 Feb 2017.